DE602005010634D1 - Peptidische Ligande die eine spezifische Bindungsfähigkeit für Immunoglobuline zeigen - Google Patents

Peptidische Ligande die eine spezifische Bindungsfähigkeit für Immunoglobuline zeigen

Info

Publication number
DE602005010634D1
DE602005010634D1 DE602005010634T DE602005010634T DE602005010634D1 DE 602005010634 D1 DE602005010634 D1 DE 602005010634D1 DE 602005010634 T DE602005010634 T DE 602005010634T DE 602005010634 T DE602005010634 T DE 602005010634T DE 602005010634 D1 DE602005010634 D1 DE 602005010634D1
Authority
DE
Germany
Prior art keywords
amino acid
residue
immunoglobulins
show
specific binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005010634T
Other languages
English (en)
Inventor
Antonio Verdoliva
Piero Bellofiore
Giovanni Cassani
Daniela Marasco
Carlo Pedone
Simona Monti
Menotti Ruvo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tecnogen SpA
Original Assignee
Tecnogen SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnogen SpA filed Critical Tecnogen SpA
Publication of DE602005010634D1 publication Critical patent/DE602005010634D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04B—TRANSMISSION
    • H04B1/00—Details of transmission systems, not covered by a single one of groups H04B3/00 - H04B13/00; Details of transmission systems not characterised by the medium used for transmission
    • H04B1/38—Transceivers, i.e. devices in which transmitter and receiver form a structural unit and in which at least one part is used for functions of transmitting and receiving
    • H04B1/3827—Portable transceivers
DE602005010634T 2004-07-30 2005-07-28 Peptidische Ligande die eine spezifische Bindungsfähigkeit für Immunoglobuline zeigen Active DE602005010634D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001569A ITMI20041569A1 (it) 2004-07-30 2004-07-30 "ligandi peptidici specifici per le immunoglobuline"

Publications (1)

Publication Number Publication Date
DE602005010634D1 true DE602005010634D1 (de) 2008-12-11

Family

ID=34956524

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005010634T Active DE602005010634D1 (de) 2004-07-30 2005-07-28 Peptidische Ligande die eine spezifische Bindungsfähigkeit für Immunoglobuline zeigen

Country Status (5)

Country Link
EP (1) EP1621546B1 (de)
AT (1) ATE412660T1 (de)
DE (1) DE602005010634D1 (de)
ES (1) ES2315787T3 (de)
IT (1) ITMI20041569A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010504997A (ja) * 2006-09-29 2010-02-18 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション 核酸導入のための多機能性キャリアとその使用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439829A (en) * 1991-01-30 1995-08-08 Eli Lilly And Company Immobilization of biologically active molecules by changing the Oxidation state of a chelated transition metal ion
ATE185147T1 (de) 1995-06-21 1999-10-15 Tecnogen Scpa Peptidliganden für die konstante region von immunoglobulinen
US6469153B1 (en) * 1998-05-20 2002-10-22 The Trustees Of Columbia University In The City Of New York EIP-1 and EIP-3 genes, envelope-interacting proteins, EIP-1 and EIP-3
DE19913707A1 (de) * 1999-03-26 2000-10-05 Privates Inst Bioserv Gmbh Immunadsorber zur Sepsistherapie
CA2290722A1 (en) * 1999-12-08 2001-06-08 Glen C. Macdonald Consensus peptide presenting entities
AU2002217843A1 (en) * 2000-11-06 2002-05-15 Thrasos, Inc. Computer method and apparatus for classifying objects
WO2002059340A1 (en) * 2001-01-26 2002-08-01 The Scripps Research Institute Immunopolypeptides to hepatitis c virus
ATE400584T1 (de) * 2001-06-14 2008-07-15 Takeda Pharmaceutical Neuer ligand und dna davon
US20030113322A1 (en) * 2001-12-18 2003-06-19 Cedric Bes CDR-H1-derived peptide CB11, pharmaceutical compositions made therefrom and methods of treating disorders in mammals
RU2206573C1 (ru) * 2001-12-27 2003-06-20 Институт молекулярной генетики РАН Семейство пептидов, обладающих нейротропными свойствами
EP1572079A4 (de) * 2002-03-29 2006-09-06 Centocor Inc Säugetier-cdr-mimetikörper, zusammensetzungen, verfahren und anwendungszwecke
JP4612270B2 (ja) * 2002-06-27 2011-01-12 靖一 田沼 生理活性ペプチドの設計法及びその用途
EP1479764A1 (de) * 2003-05-19 2004-11-24 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Heparanase-abgeleitete Peptide zur Vakzinierung von Tumorpatienten

Also Published As

Publication number Publication date
ES2315787T3 (es) 2009-04-01
ITMI20041569A1 (it) 2004-10-30
EP1621546A1 (de) 2006-02-01
EP1621546B1 (de) 2008-10-29
ATE412660T1 (de) 2008-11-15

Similar Documents

Publication Publication Date Title
DE60026875D1 (de) Zink-aminosäure-chelate mit glyzin und einer schwefelhaltigen aminosäure als liganden
DE602005023315D1 (de) Antimikrobielle peptide mit einem arginin- und /oder lysin-haltigen motiv
PT2360176E (pt) Expressão híbrida e em série de proteínas derivadas de neisseria
DK1509212T3 (da) Hidtil ukendte chromium-(III)-a-aminosyrekomplekser
WO2004075655A3 (en) Method for reducing acrylamide formation in thermally processed foods
IL142025A0 (en) Novel methods for displaying (poly) peptides/proteins on bacteriophage particles via disulfide bonds
ES2162637T3 (es) Estimulacion del crecimiento del pelo por complejos de peptido-cobre.
CY1110397T1 (el) Πολυπεπτιδιο που εχει βελτιωμενη δραστικοτητα αποαμινασης κυτοσινης
WO2002038592A3 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
ATE421972T1 (de) Polypeptid zur verwendung als biomaterial und prozess zur herstellung davon
EA200701727A1 (ru) Связанные с матрицей бета-шпилечные пептидомиметики с ингибирующей активностью в отношении протеаз
DE602005010874D1 (en) Polypeptid
DE602005010634D1 (de) Peptidische Ligande die eine spezifische Bindungsfähigkeit für Immunoglobuline zeigen
ATE280827T1 (de) Penaeidine: antimikrobielle peptide aus krebstieren
IL141647A0 (en) Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
CA2379908A1 (en) Preparation of metal complexes of amino acids obtained by hydrolysis of soy protein
EP1666880A4 (de) Screening-verfahren
AU2002355742A8 (en) Crfr1 selective ligands
RU2229897C2 (ru) Бактерициды на основе хелатных комплексов металлов
Panossian et al. Zinc (II) and Nickel (II) Complexes of Cysteinyl-Cysteine
US20170296560A1 (en) 2-aminoethanol dihydrogen phosphate-based dietary supplement and synthesis process thereof
EP1978026A4 (de) Neue t-helper antigenic determinant (thd) peptide
WO2002042413A3 (en) Methods and compositions involved in groucho-mediated differentiation
WO2003040176A3 (fr) Leurres peptidiques pour la preparation de medicaments destines a la prevention ou au traitement des pathologies auto-immunes, ou des troubles lies a l'apparition d'anticorps diriges contre des proteines exogenes
WO2002099045A3 (en) Peptide beta-strand mimics based on 1,2-dihydro-3(6h)-pyridinone

Legal Events

Date Code Title Description
8364 No opposition during term of opposition